3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
13
Thoracic
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Obesity-Related Malignant Neoplasm
4
Obesity
4
Overweight
2
Syndrome
1
Sedentary Behavior
1
Prostatic Neoplasms
1
Neoplasms
1
Mucositis
1
Lung Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Fatigue
1
Dyspnea
1
Disease
1
Cough
1
Chemotherapy-Induced Peripheral Neuropathy
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Abnormalities, Radiation-Induced
1
Interventions
Resistance Training
4
Nutrition Assessment
4
naloxegol
3
Surveys and Questionnaires
3
Exercise
3
alvimopan
2
Therapeutics
2
Psychiatric Rehabilitation
2
Oxygen
2
Nutritional Status
2
Mouthwashes
2
Morphine
2
Ketamine
2
Interviews as Topic
2
Fibroblast Growth Factor 7
2
Counseling
2
semaglutide
1
naldemedine
1
methylnaltrexone
1
ma zi ren wan
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
calcium phosphate
1
auricularum
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Weights and Measures
1
Walking
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Educational Status
×
Other
×
Clear all
NCT01421758
2016-04-19
INSHAPE
University of North Carolina, Chapel Hill
Phase NA
Completed
134 enrolled